Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2021

Share-based Payment Arrangement [Abstract]

Schedule of stock-based compensation expense stock options and restricted stock

	Three Months Ended		Three Months Ended
	March 31, 2021		March 31, 2020
Research and development	$	67,279	$	—
General and administrative		963,136		425,844
	$	1,030,415	$	425,844

Schedule of fair value of employee stock options

	Three  Months March 31, 2021
Weighted average exercise price	$	15.90
Weighted average grant date fair value	$	13.72
Assumptions
Expected volatility		89	%
Weighted average expected term (in years)		10.0
Risk-free interest rate		1.09	%
Expected dividend yield		0.00	%

Schedule of stock option activity

	Number of Shares			Weighted- Average Exercise Prices		Weighted- Average Remaining Contractual Term (In Years)		Intrinsic Value
Outstanding at January 1, 2021		2,610,495		$	5.63		8.60	$	22,789,233
Granted		10,000			15.90		—		—
Exercised		(244,656	)		2.68		—		—
Outstanding at March 31, 2021		2,375,839		$	5.98		8.45	$	18,262,737
Exercisable at March 31, 2021		660,382		$	3.61		7.98	$	6,576,440